Forgot your password? 
New user? | Show: 1 - 6 of 6 results |
China's Kaifeng Pharmaceutical Expands Footprint in International API Markets
|
[posted: December 02, 2008] China's Kaifeng Pharmaceutical (Group), a subsidiary of Henan province-based Furen Medicines Group, is moving forward with its plan to grab a larger share of the global pharmaceutical market by seeking international certification and expanding its API ... details |
China's Pharmaceutical Sector Records Trade Surplus of US$3 billion in 1H 2008
|
[posted: October 28, 2008] China's pharmaceutical sector posted combined imports and exports of approx. US$13.7 billion for the first six months of 2008, up 49.7 percent from a year earlier. Imports jumped 42.8 percent year-on-year to US$5.3 billion, while exports grew 54.5 percent to US$8.3 billion ... details |
Zhejiang Hisoar Enters Contract Manufacture Agreement with Boehringer Ingelheim
|
[posted: August 13, 2008] Zhejiang Hisoar Pharmaceutical Co. Ltd., a leading Chinese API producer, recently announced the signing of a framework agreement with Boehringer Ingelheim International under which Hisoar will contract manufacture selected drug proudcts for Boehringer Ingelheim ... details |
Huifeng Signs US$1.1M Supply Agreement with DNP
|
[posted: August 11, 2008] Huifeng Bio-Pharmaceutical Technology Inc. (OTCBB: HFGB), a Chinese drug company based in XiAn, Shaanxi province, announced on August 11 that it signed a major supply agreement with DNP International Co. Inc., California. Under terms of the agreement, Huifeng will supply 62 metric tons of glucuronolactone ... details |
Prices of Key Bulk Drugs Falls with Expected Supply Rise from China
|
[posted: August 11, 2008] With China expected to reopen several hundred bulk drug manufacturing facilities after the Beijing Olympics, prices of some key bulk drugs, including penicillin and paracetamol, have crashed in the Indian market. Industry sources said the price of an antibiotic like Erythromycin ... details |
Zhejiang Huahai Pharma and MSD Enter Contract Manufacture Framework Agreement
|
[posted: July 25, 2008] Zhejiang Huahai Pharmaceutical Ltd., a leading pharmaceutical exporter and CMO in China, announced on July 24 that it had signed a framework agreement with Merck, Sharp and Dhome (MSD) to contract manufacture the finished product of a patented drug of MSD for exclusive sales by MSD globally ... details |
« Previous [ 1 ] Next »
